Table of Contents
<< Previous Issue | Jul 2018 (Vol: 2018, Issue: 7) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Keryx And Akebia Unite to Create a Chronic Kidney Disease Specialist
-
CVC Capital Acquires Controlling Stake in Recordati
-
Otsuka Bolsters Pipeline with Acquisition of Antibody Developer Visterra
- Section: Research & Development
-
Novo Nordisk Signs Diabetes and Obesity Collaboration with Kallyope
-
AbbVie Adds Depth to Pipeline With Calico And Calibr Deals
-
Axovant Focuses on Gene Therapy with Benitec Partnership
-
Genmab Partners With Immatics To Discover and Develop Next-Generation Immunotherapies